Domov › Akutna mieločna levkemija › Kalifornija › Baldwin Park
Klinične študije za Akutna mieločna levkemija v Baldwin Park, CA
40 študij za Akutna mieločna levkemija išče udeležence na lokacijah v Baldwin Park in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.
Uradno besedilo študije (angleško)
Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →
A Study to Assess Adverse Events and Change in Disease Activity When Intravenous (IV) Pivekimab Sunirine is Given in Combination With Oral Venetoclax and IV or Subcutaneous Azacitidine in Adult Participants With Acute Myeloid Leukemia (AML)
Vključevanje udeležencevFaza 2/3
- City of Hope National Medical Center /ID# 279568, Duarte · 4 mi stran
A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
Vključevanje udeležencevFaza 1
- City of Hope, Duarte · 4 mi stran
A Phase 1 Study of AOH1996 in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Vključevanje udeležencevFaza 1
- City of Hope Medical Center, Duarte · 4 mi stran
Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation
Vključevanje udeležencevFaza 3
- Clinical Trial Site, Duarte · 4 mi stran
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
Vključevanje udeležencevFaza 3
- City of Hope, Duarte · 4 mi stran
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Vključevanje udeležencevFaza 3
- City of Hope Comprehensive Cancer Center, Duarte · 4 mi stran
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
Vključevanje udeležencevFaza 2
- City of Hope Comprehensive Cancer Center, Duarte · 4 mi stran
Phase 1 Study of AUTX-703 in Relapsed/Refractory AML and MDS
Vključevanje udeležencevFaza 1
- City of Hope National Medical Center, Duarte · 4 mi stran
The Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis After Reduced Intensity Conditioning and Peripheral Blood Stem Cell Transplantation
Vključevanje udeležencevFaza 1/2Vabljeni zdravi prostovoljci
- City of Hope, Duarte · 4 mi stran
A Study to Assess the Safety, Tolerability, and Antileukemic Activity of Debio 1562M in Participants With Acute Myeloid Leukemia (AML)
Vključevanje udeležencevFaza 1/2
- City of Hope Comprehensive Cancer Center, Duarte · 4 mi stran
Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML
Vključevanje udeležencevFaza 1/2
- City of Hope National Medical Center, Duarte · 4 mi stran
MiRisten for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia
Vključevanje udeležencevFaza 1
- City of Hope Medical Center, Duarte · 4 mi stran
Eganelisib as Monotherapy and in Combination With Cytarabine in Relapsed/Refractory AML
Vključevanje udeležencevFaza 1
- City of Hope, Duarte · 4 mi stran
8-Chloroadenosine in Combination With Venetoclax for the Treatment of Patients With Relapsed/Refractory Acute Myeloid Leukemia
Vključevanje udeležencevFaza 1
- City of Hope Medical Center, Duarte · 4 mi stran
Individualized AML Treatment
Vključevanje udeležencevOpazovalna študija
- City of Hope Medical Center, Duarte · 4 mi stran
Total Marrow and Lymphoid Irradiation in Combination With Fludarabine and Melphalan as Conditioning for Allogeneic Peripheral Blood Stem Cell Hematopoietic Cell Transplant in Older Patients With Refractory and Relapsed Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome
Vključevanje udeležencevFaza 2
- City of Hope Medical Center, Duarte · 4 mi stran
225Ac-DOTA-Anti-CD38 Daratumumab Monoclonal Antibody With Fludarabine, Melphalan and Total Marrow and Lymphoid Irradiation as Conditioning Treatment for Donor Stem Cell Transplant in Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Myelodysplastic Syndrome
Vključevanje udeležencevFaza 1
- City of Hope Medical Center, Duarte · 4 mi stran
A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant
Vključevanje udeležencevFaza 1Vabljeni zdravi prostovoljci
- City of Hope Medical Center, Duarte · 4 mi stran
Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT
Vključevanje udeležencevFaza 3
- City of Hope Comprehensive Cancer Center - Duarte, Duarte · 4 mi stran
Tagraxofusp and Azacitidine for Maintenance Treatment in Patients With CD123 Positive AML and MDS Following Donor Hematopoietic Cell Transplant
Vključevanje udeležencevFaza 1
- City of Hope Medical Center, Duarte · 4 mi stran
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Vključevanje udeležencevOpazovalna študija
- City of Hope, Duarte · 4 mi stran
Emapalumab With Post-Transplant Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Graft-versus-Host Disease After Donor Reduced-Intensity Hematopoietic Cell Transplant
Vključevanje udeležencevFaza 1
- City of Hope Medical Center, Duarte · 4 mi stran
Vedolizumab Plus Post-transplant Cyclophosphamide and Short Course Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation After Reduced Intensity Conditioning
Vključevanje udeležencevFaza 2
- City of Hope Medical Center, Duarte · 4 mi stran
A Study of Revumenib and Mezigdomide in People With Leukemia
Vključevanje udeležencevFaza 1/2
- City of Hope Cancer Center (Data collection only), Duarte · 4 mi stran
SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
Vključevanje udeležencevFaza 1
- City of Hope, Duarte · 4 mi stran
Orca-T Following Chemotherapy and Total Marrow and Lymphoid Irradiation for the Treatment of Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia or Myelodysplastic Syndrome
Vključevanje udeležencevFaza 1Vabljeni zdravi prostovoljci
- City of Hope Medical Center, Duarte · 4 mi stran
Study of Talazoparib in Combination With Chemotherapy in Relapsed Pediatric AML to Determine Safety and Efficacy
Vključevanje udeležencevFaza 1
- City of Hope, Duarte · 4 mi stran
A Study of GLB-001 in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher Risk Myelodysplastic Syndromes
Vključevanje udeležencevFaza 1
- City of Hope Medical Center, Duarte · 4 mi stran
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
Vključevanje udeležencevFaza 2
- City of Hope, Duarte · 4 mi stran
A Study of CBX-250 in Participants With Relapsed or Refractory Myeloid Leukemias
Vključevanje udeležencevFaza 1
- City of Hope, Duarte · 4 mi stran
CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant
Vključevanje udeležencevFaza 2Vabljeni zdravi prostovoljci
- City of Hope Medical Center, Duarte · 4 mi stran
CD33-CAR T Cell Therapy for the Treatment of Recurrent or Refractory Acute Myeloid Leukemia
Vključevanje udeležencevFaza 1
- City of Hope Medical Center, Duarte · 4 mi stran
Olutasidenib for the Treatment of Patients With IDH1 Mutated AML, MDS or CMML After Donor Hematopoietic Cell Transplant
Vključevanje udeležencevFaza 1
- City of Hope Medical Center, Duarte · 4 mi stran
Revumenib for the Treatment of Acute Leukemia in Patients Post-Allogeneic Stem Cell Transplant
Vključevanje udeležencevFaza 1
- City of Hope Medical Center, Duarte · 4 mi stran
Safety of MT-401-OTS in Patients With Relapsed AML or MDS
Vključevanje udeležencevFaza 1
- City of Hope Center (City of Hope National Medical Center, City of Hope Medical Center), Duarte · 4 mi stran
Ruxolitinib With Tacrolimus and Methotrexate for the Prevention of Graft Versus Host Disease in Pediatric and Young Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplant for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome
Vključevanje udeležencevFaza 2
- City of Hope Medical Center, Duarte · 4 mi stran
Study of NMS-03597812 in Adult Patients With Relapsed/Refractory Acute Myeloid Leukemia
Vključevanje udeležencevFaza 1
- City of Hope - Duarte, Duarte · 4 mi stran
A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome
Vključevanje udeležencevFaza 1
- City of Hope Medical Center, Duarte · 4 mi stran
Study of REM-422 in Patients With AML or Higher Risk MDS
Vključevanje udeležencevFaza 1
- City of Hope, Duarte · 4 mi stran
A Study of BTX-A51 in People With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
Vključevanje udeležencevFaza 1
- City of Hope National Medical Center, Duarte · 4 mi stran
Študije za Akutna mieločna levkemija v drugih mestih
- Houston, TX85 študij
- New York City, NY51 študij
- Boston, MA44 študij
- Seattle, WA41 študij
- Columbus, OH35 študij
- Philadelphia, PA34 študij
- Durham, NC33 študij
- Atlanta, GA31 študij
- Tampa, FL29 študij
- Chicago, IL26 študij
- Portland, OR25 študij
- Washington, DC24 študij
Druge študije v Baldwin Park
- Rak dojke44 študij
- Kolorektalni rak37 študij
- Nemalicelični pljučni rak36 študij
- Rak (vse vrste)34 študij
- Rak prostate30 študij
- Metastatski rak30 študij
- Mielodisplastični sindromi26 študij
- Rak jajčnikov25 študij
- Rak pljuč24 študij
- Množni mielom23 študij
- Rak želodca22 študij
- Akutna limfoblastna levkemija21 študij
Vir: ClinicalTrials.gov, podatki pridobljeni 6. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.